M. Matin, A. Asilian, Samaneh Mozafar Poor, Elaheh Haftbaradaran, A. Feily
{"title":"Treatment of Cutaneous Lymphoid Hyperplasia with Rituximab: A Case Report of 3 Patients","authors":"M. Matin, A. Asilian, Samaneh Mozafar Poor, Elaheh Haftbaradaran, A. Feily","doi":"10.35248/2684-124X.19.4.150","DOIUrl":null,"url":null,"abstract":"Benign Cutaneous Lymphoid Hyperplasia (CLH) is a B-cell pseudolymphoma of an unknown origin. The face is the most affected site in CLH. This report presents the cases of 3 patients with CLH who were treated with rituximab. \n \nIt is a hypothesis that rituximab is useful for treating resistant-to-relapsing forms of CLH that do not respond to previous therapies but must be checked with appropriate designs research.","PeriodicalId":92997,"journal":{"name":"Dermatology case reports","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology case reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2684-124X.19.4.150","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Benign Cutaneous Lymphoid Hyperplasia (CLH) is a B-cell pseudolymphoma of an unknown origin. The face is the most affected site in CLH. This report presents the cases of 3 patients with CLH who were treated with rituximab.
It is a hypothesis that rituximab is useful for treating resistant-to-relapsing forms of CLH that do not respond to previous therapies but must be checked with appropriate designs research.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
